370 related articles for article (PubMed ID: 27919654)
1. American Brachytherapy Society: Brachytherapy treatment recommendations for locally advanced cervix cancer for low-income and middle-income countries.
Suneja G; Brown D; Chang A; Erickson B; Fidarova E; Grover S; Mahantshetty U; Nag S; Narayan K; Bvochora-Nsingo M; Viegas C; Viswanathan AN; Lin MY; Gaffney D
Brachytherapy; 2017; 16(1):85-94. PubMed ID: 27919654
[TBL] [Abstract][Full Text] [Related]
2. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: low-dose-rate and pulsed-dose-rate brachytherapy.
Lee LJ; Das IJ; Higgins SA; Jhingran A; Small W; Thomadsen B; Viswanathan AN; Wolfson A; Eifel P;
Brachytherapy; 2012; 11(1):53-7. PubMed ID: 22265438
[TBL] [Abstract][Full Text] [Related]
3. The American Brachytherapy Society recommendations for low-dose-rate brachytherapy for carcinoma of the cervix.
Nag S; Chao C; Erickson B; Fowler J; Gupta N; Martinez A; Thomadsen B;
Int J Radiat Oncol Biol Phys; 2002 Jan; 52(1):33-48. PubMed ID: 11777620
[TBL] [Abstract][Full Text] [Related]
4. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix.
Nag S; Erickson B; Thomadsen B; Orton C; Demanes JD; Petereit D
Int J Radiat Oncol Biol Phys; 2000 Aug; 48(1):201-11. PubMed ID: 10924990
[TBL] [Abstract][Full Text] [Related]
5. The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries.
Grover S; Lichter KE; Likhacheva A; Jang JW; Ning MS; Robin TP; Small W; Kudchadker RJ; Swamidas J; Chopra S; Rai B; Sharma SD; Sharma DN; Kuppusamy T; Yang R; Berger D; Mendez LC; Glaser S; Erickson DL; Chino J; Mourtada F; Abdel-Wahab M; Jhingran A; Simonds H; Mahantshetty U
Brachytherapy; 2023; 22(6):716-727. PubMed ID: 37704540
[TBL] [Abstract][Full Text] [Related]
6. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part I: general principles.
Viswanathan AN; Thomadsen B; ;
Brachytherapy; 2012; 11(1):33-46. PubMed ID: 22265436
[TBL] [Abstract][Full Text] [Related]
7. American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part II: high-dose-rate brachytherapy.
Viswanathan AN; Beriwal S; De Los Santos JF; Demanes DJ; Gaffney D; Hansen J; Jones E; Kirisits C; Thomadsen B; Erickson B;
Brachytherapy; 2012; 11(1):47-52. PubMed ID: 22265437
[TBL] [Abstract][Full Text] [Related]
8. Image Guided Cervical Brachytherapy: 2014 Survey of the American Brachytherapy Society.
Grover S; Harkenrider MM; Cho LP; Erickson B; Small C; Small W; Viswanathan AN
Int J Radiat Oncol Biol Phys; 2016 Mar; 94(3):598-604. PubMed ID: 26867888
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional imaging in gynecologic brachytherapy: a survey of the American Brachytherapy Society.
Viswanathan AN; Erickson BA
Int J Radiat Oncol Biol Phys; 2010 Jan; 76(1):104-9. PubMed ID: 19619956
[TBL] [Abstract][Full Text] [Related]
10. Cervix Cancer Research Network (CCRN): Improving Access to Cervix Cancer Trials on a Global Scale.
Gaffney D; Small B; Kitchener H; Young Ryu S; Viswanathan A; Trimble T; Covens A; Wilailak S; Lertkhachonsuk AA; Sitathanee C; Mahantshetty U; Fisher B; Springer S; Pollatz T; Spiller A; Bacon M; Jhingran A
Int J Gynecol Cancer; 2016 Nov; 26(9):1690-1693. PubMed ID: 27779548
[TBL] [Abstract][Full Text] [Related]
11. Phase II study of the American Brachytherapy Society guidelines for the use of high-dose rate brachytherapy in the treatment of cervical carcinoma: is 45-50.4 Gy radiochemotherapy plus 31.8 Gy in six fractions high-dose rate brachytherapy tolerable?
Shakespeare TP; Lim KH; Lee KM; Back MF; Mukherjee R; Lu JD;
Int J Gynecol Cancer; 2006; 16(1):277-82. PubMed ID: 16445645
[TBL] [Abstract][Full Text] [Related]
12. Proposed guidelines for image-based intracavitary brachytherapy for cervical carcinoma: report from Image-Guided Brachytherapy Working Group.
Nag S; Cardenes H; Chang S; Das IJ; Erickson B; Ibbott GS; Lowenstein J; Roll J; Thomadsen B; Varia M;
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1160-72. PubMed ID: 15519788
[TBL] [Abstract][Full Text] [Related]
13. Magnetic Resonance Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: An Experience From a Tertiary Cancer Center in a Low and Middle Income Countries Setting.
Mahantshetty U; Krishnatry R; Hande V; Jamema S; Ghadi Y; Engineer R; Chopra S; Gurram L; Deshpande D; Shrviastava S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(3):608-617. PubMed ID: 29280456
[TBL] [Abstract][Full Text] [Related]
14. The American brachytherapy society survey of brachytherapy practice for carcinoma of the cervix in the United States.
Nag S; Orton C; Young D; Erickson B
Gynecol Oncol; 1999 Apr; 73(1):111-8. PubMed ID: 10094890
[TBL] [Abstract][Full Text] [Related]
15. Radiation Oncology Management of Stage I-III Cervix Cancer.
de Souza Lawrence L
Surg Oncol Clin N Am; 2017 Jul; 26(3):477-489. PubMed ID: 28576184
[TBL] [Abstract][Full Text] [Related]
16. Technically accurate intracavitary insertions improve pelvic control and survival among patients with locally advanced carcinoma of the uterine cervix.
Corn BW; Hanlon AL; Pajak TF; Owen J; Hanks GE
Gynecol Oncol; 1994 Jun; 53(3):294-300. PubMed ID: 8206401
[TBL] [Abstract][Full Text] [Related]
17. Effect of tumor dose, volume and overall treatment time on local control after radiochemotherapy including MRI guided brachytherapy of locally advanced cervical cancer.
Tanderup K; Fokdal LU; Sturdza A; Haie-Meder C; Mazeron R; van Limbergen E; Jürgenliemk-Schulz I; Petric P; Hoskin P; Dörr W; Bentzen SM; Kirisits C; Lindegaard JC; Pötter R
Radiother Oncol; 2016 Sep; 120(3):441-446. PubMed ID: 27350396
[TBL] [Abstract][Full Text] [Related]
18. Addressing the burden of cervical cancer through IAEA global brachytherapy initiatives.
Abdel-Wahab M; Grover S; Zubizarreta EH; Polo Rubio JA
Brachytherapy; 2020; 19(6):850-856. PubMed ID: 32928684
[TBL] [Abstract][Full Text] [Related]
19. High-dose-rate intracavitary brachytherapy combined with external beam radiotherapy for stage IIIb adenocarcinoma of the uterine cervix in Japan: a multi-institutional study of Japanese Society of Therapeutic Radiology and Oncology 2006-2007 (study of JASTRO 2006-2007).
Niibe Y; Kenjo M; Onishi H; Ogawa Y; Kazumoto T; Ogino I; Tsujino K; Harima Y; Takahashi T; Anbai A; Tsuchida E; Toita T; Takemoto M; Yamashita H; Hayakawa K
Jpn J Clin Oncol; 2010 Aug; 40(8):795-9. PubMed ID: 20444747
[TBL] [Abstract][Full Text] [Related]
20. Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer.
Pötter R; Dimopoulos J; Georg P; Lang S; Waldhäusl C; Wachter-Gerstner N; Weitmann H; Reinthaller A; Knocke TH; Wachter S; Kirisits C
Radiother Oncol; 2007 May; 83(2):148-55. PubMed ID: 17531904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
